CD44 is of particular interest, as it is widely expressed in the tumor cells of breast carcinomas [21] and has been shown to promote tumor growth and mediate drug resistance by maintaining cancer stem cell populations [27,28,29]. This evidence concerns the gene CD44 and breast carcinoma.